Back to Search Start Over

Zanubrutinib PLUS RCHOP(ZR-CHOP) Regimen Achieves High Complete Response Rate in the Treatment of Newly-Diagnosed Double-Expression Diffuse Large B Cell Lymphoma

Authors :
Qiang He
Linna Xie
Rongrong Zhao
Ji Ma
Hui Wang
Jie Li
Chuanli Zhao
Y. Lynn Wang
Zengjun Li
Source :
Blood. 140:6614-6615
Publication Year :
2022
Publisher :
American Society of Hematology, 2022.

Details

ISSN :
15280020 and 00064971
Volume :
140
Database :
OpenAIRE
Journal :
Blood
Accession number :
edsair.doi...........922e3f85fe61b1bf28e80e5d7464a1ff
Full Text :
https://doi.org/10.1182/blood-2022-168859